Key Highlights
•
A new digital seed amplification assay (dSAA) was developed to precisely quantify TDP-43 protein aggregates in cerebrospinal fluid, showing elevated seed concentrations in patients with frontotemporal lobar dementia. This breakthrough offers a sensitive diagnostic tool that could improve the accuracy of dementia diagnosis and help monitor disease progression in TDP-43-related disorders.
Source →
•
The DISTAL trial found that endovascular treatment plus best medical treatment for medium or distal vessel occlusion stroke did not reduce disability or death at 12 months compared to best medical treatment alone. These consistent results with the 90-day findings do not support routine endovascular treatment for patients with mild-to-moderate medium or distal vessel occlusion stroke.
Source →
•
The CORRECT-BD trial compared right unilateral ultrabrief electroconvulsive therapy against magnetic seizure therapy for bipolar depression, examining clinical and cognitive outcomes. This study provides crucial head-to-head data on two brain stimulation treatments, informing clinical decisions for managing bipolar depression.
Source →
•
Radiotherapy followed by adjuvant temozolomide was shown to improve survival for patients with aggressive IDH-mutated anaplastic glioma. This treatment regimen represents an important advance in the management of this aggressive brain tumor type.
Source →
•
A case report documented a posterior epidural migrated disc mimicking a tumor, highlighting a rare spinal presentation that can be mistaken for malignancy. This finding underscores the importance of considering disc herniations in the differential diagnosis of spinal tumors.
Source →
Stay curious. Stay informed —
Science Briefing
